Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Xbiotech Inc (XBIT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
[[ ctrl.chartTitle ]]
Full Chart

Fundamentals

See More
  • Market Capitalization, $K 156,729
  • Shares Outstanding, K 35,220
  • Annual Sales, $ 0 K
  • Annual Income, $ -52,760 K
  • 36-Month Beta 0.56
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.15

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.09 +7.58%
on 09/26/17
4.72 -6.78%
on 10/13/17
-0.08 (-1.79%)
since 09/15/17
3-Month
3.55 +23.94%
on 08/03/17
5.51 -20.15%
on 07/19/17
-1.02 (-18.82%)
since 07/17/17
52-Week
2.77 +58.84%
on 06/09/17
20.18 -78.20%
on 03/27/17
-9.52 (-68.39%)
since 10/17/16

Most Recent Stories

More News
XBiotech Announces Addition of Renowned Dermatologist Dr. William Levis to its Scientific Advisory Board

XBiotech Inc. (NASDAQ:XBIT) is pleased to announce the appointment of William Levis, MD to its Scientific Advisory Board (SAB). Dr. Levis will work with XBiotech to help advance the clinical program in...

XBIT : 4.41 (-0.90%)
XBiotech to Present at Cantor Fitzgerald's Global Healthcare Conference

AUSTIN, Texas, Sept. 21, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today that management will be presenting at Cantor Fitzgerald's Global Healthcare Conference taking place September...

XBIT : 4.41 (-0.90%)
XBiotech to Present at Cantor Fitzgerald's Global Healthcare Conference

XBiotech Inc. (NASDAQ:XBIT) announced today that management will be presenting at Cantor Fitzgerald's Global Healthcare Conference taking place September 25-27 at the InterContinental New York Barclay...

XBIT : 4.41 (-0.90%)
XBiotech Announces Agreement with Cedars-Sinai Medical Center to Evaluate MABp1 in Combination with Onivyde(R) and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer

AUSTIN, Texas, Sept. 20, 2017 (GLOBE NEWSWIRE) -- XBiotech Inc. (NASDAQ:XBIT) announced today its agreement with Cedars-Sinai Medical Center located in Los Angeles, California, whereby XBiotech will provide...

XBIT : 4.41 (-0.90%)
XBiotech Announces Agreement with Cedars-Sinai Medical Center to Evaluate MABp1 in Combination with Onivydeâ"? and 5-fluorouracil/folinic acid for the Treatment of Pancreatic Cancer

XBiotech Inc. (NASDAQ:XBIT) announced today its agreement with Cedars-Sinai Medical Center located in Los Angeles, California, whereby XBiotech will provide its interleukin-1 alpha antagonist, MABp1, for...

XBIT : 4.41 (-0.90%)
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces an Investigation Involving Possible Securities Fraud Violations by Certain Officers and Directors of XBiotech Inc.

Levi & Korsinsky, LLP announces it has commenced an investigation of XBiotech Inc. ("XBiotech") (NASDAQ:XBIT) concerning possible violations of federal securities laws.

XBIT : 4.41 (-0.90%)
Stocks Under Scanner in the Biotech Space -- Acorda Therapeutics, Advaxis, Xbiotech, and Akebia Therapeutics

If you want a Stock Review on ACOR, ADXS, XBIT, or AKBA then come over to http://dailystocktracker.com/register/ and sign up for your free customized report today. On Friday, September 08, 2017, the NASDAQ...

ADXS : 4.08 (+3.82%)
AKBA : 18.19 (-1.17%)
ACOR : 26.65 (+2.30%)
XBIT : 4.41 (-0.90%)
XBiotech Announces Presentation of Phase 2 Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa

XBiotech Inc. (NASDAQ:XBIT) announced today that results from the investigator sponsored randomized Phase 2 study evaluating XBiotech's True Human(TM) antibody, MABp1, as a treatment for Hidradenitis Suppurativa...

XBIT : 4.41 (-0.90%)
XBiotech Announces Presentation of Phase 2 Study Data Evaluating MABp1 for the Treatment of Hidradenitis Suppurativa

Results of the Randomized Phase 2 Study Evaluating MABp1 for the Treatment of Hidradenitis Suppurati

XBIT : 4.41 (-0.90%)
Xbiotech Inc Has Returned 16.7% Since SmarTrend Recommendation (XBIT)

SmarTrend identified a Downtrend for Xbiotech Inc (NASDAQ:XBIT) on June 9th, 2017 at $6.27. In approximately 1 month, Xbiotech Inc has returned 16.75% as of today's recent price of $5.22.

XBIT : 4.41 (-0.90%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Sell with a Average short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

XBiotech Inc. is a biopharmaceutical company. The Company is engaged in discovering and developing True Human(TM) monoclonal antibodies for treating diseases. XBiotech Inc. is based in AUSTIN, United States.

See More

Support & Resistance

2nd Resistance Point 4.79
1st Resistance Point 4.62
Last Price 4.41
1st Support Level 4.35
2nd Support Level 4.25

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart